{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:15:39Z","timestamp":1786979739319,"version":"build-2736575974"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000374","name":"british medical association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000374","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00198-021-06197-7","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T14:24:35Z","timestamp":1633962275000},"page":"931-935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of subtrochanteric and femoral shaft fractures due to bisphosphonate therapy in asthma: a population-based nested case\u2013control study"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0836-9385","authenticated-orcid":false,"given":"C. V.","family":"Chalitsios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4106-8469","authenticated-orcid":false,"given":"D. E.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-0416","authenticated-orcid":false,"given":"T. M.","family":"McKeever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"6197_CR1","doi-asserted-by":"publisher","first-page":"2001251","DOI":"10.1183\/13993003.01251-2020","volume":"57","author":"CV Chalitsios","year":"2021","unstructured":"Chalitsios CV, McKeever TM, Shaw DE (2021) Incidence of osteoporosis and fragility fractures in asthma: a UK population-based matched cohort study. Eur Respir J. 57:2001251","journal-title":"Eur Respir J."},{"key":"6197_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1136\/thoraxjnl-2020-215664","volume":"76","author":"CV Chalitsios","year":"2021","unstructured":"Chalitsios CV, Shaw DE, McKeever TM (2021) Risk of osteoporosis and fragility fractures in asthma due to oral and inhaled corticosteroids: two population-based nested case-control studies. Thorax 76:21\u20138","journal-title":"Thorax"},{"issue":"19","key":"6197_CR3","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1056\/NEJMc062268","volume":"355","author":"R Armamento-Villareal","year":"2006","unstructured":"Armamento-Villareal R, Napoli N, Panwar V, Novack D (2006) Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis. N Engl J Med 355(19):2048\u20132050","journal-title":"N Engl J Med"},{"issue":"8","key":"6197_CR4","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/jbmr.1893","volume":"28","author":"L Gedmintas","year":"2013","unstructured":"Gedmintas L, Solomon DH, Kim SC (2013) Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta-analysis. J Bone Miner Res 28(8):1729\u20131737","journal-title":"J Bone Miner Res"},{"issue":"8","key":"6197_CR5","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1056\/NEJMoa1916525","volume":"383","author":"DM Black","year":"2020","unstructured":"Black DM, Geiger EJ, Eastell R, Vittinghoff E, Li BH, Ryan DS et al (2020) Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates. N Engl J Med 383(8):743\u2013753","journal-title":"N Engl J Med"},{"issue":"10","key":"6197_CR6","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1056\/NEJMc1403799","volume":"371","author":"J Schilcher","year":"2014","unstructured":"Schilcher J, Koeppen V, Aspenberg P (2014) Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med 371(10):973\u2013974","journal-title":"N Engl J Med"},{"key":"6197_CR7","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","volume":"364","author":"J Schilcher","year":"2011","unstructured":"Schilcher J, Micha\u00eblsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364:1728\u20131737","journal-title":"N Engl J Med"},{"issue":"5","key":"6197_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/MLR.0000000000001294","volume":"58","author":"JR Curtis","year":"2020","unstructured":"Curtis JR, Saag KG, Arora T, Wright NC, Yun H, Daigle S et al (2020) Duration of bisphosphonate drug holidays and associated fracture risk. Med Care 58(5):419\u2013426","journal-title":"Med Care"},{"issue":"7","key":"6197_CR9","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1002\/jbmr.3420","volume":"33","author":"AL Adams","year":"2018","unstructured":"Adams AL, Adams JL, Raebel MA, Tang BT, Kuntz JL, Vijayadeva V et al (2018) Bisphosphonate drug holiday and fracture risk: a population-based cohort study. J Bone Miner Res 33(7):1252\u20131259","journal-title":"J Bone Miner Res"},{"issue":"2","key":"6197_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1210\/er.2018-00001","volume":"40","author":"DM Black","year":"2019","unstructured":"Black DM, Abrahamsen B, Bouxsein ML, Einhorn T, Napoli N (2019) Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management. Endocr Rev 40(2):333\u2013368","journal-title":"Endocr Rev"},{"key":"6197_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B et al (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"6197_CR12","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jama.2011.190","volume":"305","author":"LY Park-Wyllie","year":"2011","unstructured":"Park-Wyllie LY, Mamdani MM, Juurlink DN et al (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305:783\u2013789","journal-title":"JAMA"},{"key":"6197_CR13","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/1099-1557(200009\/10)9:5<359::AID-PDS507>3.0.CO;2-E","volume":"9","author":"T van Staa","year":"2000","unstructured":"van Staa T, Abenhaim L, Cooper C, Zhang B, Leufkens H (2000) The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 9:359\u2013366","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06197-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-021-06197-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-021-06197-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,17]],"date-time":"2022-03-17T23:02:51Z","timestamp":1647558171000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-021-06197-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6197"],"URL":"https:\/\/doi.org\/10.1007\/s00198-021-06197-7","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"23 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Independent Scientific Advisory Group of the CPRD (ISAC protocol number 19_041RA).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}